“And then we can test the biology. And do you think that just intermittent dosing of Everolimus or serolimus gets that? Maybe. Again, it's hard to tell in healthy people because, you know, in cancer, when you study mTOR inhibitors, the cancers have a highly upregulated pathway, and it's easy to see the biology.”
Discussed